Aadi Bioscience adds Baiteng Zhao to board
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 19 2024
0mins
Source: Business Insider
Aadi Bioscience Board Appointment: Baiteng Zhao has joined Aadi Bioscience's board of directors, bringing experience from his role as co-founder and CEO of ProfoundBio, which was acquired by Genmab.
Zhao's Background: Before ProfoundBio, Zhao worked at Seagen for over eight years, focusing on modeling and simulation strategies for ADC drug development.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
